QuidelOrtho Corp. Stock
€38.80
Your prediction
QuidelOrtho Corp. Stock
Pros and Cons of QuidelOrtho Corp. in the next few years
Pros
Cons
Performance of QuidelOrtho Corp. vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
QuidelOrtho Corp. | -0.510% | -3.465% | 5.978% | -50.869% | -42.495% | -60.414% | - |
Boston Scientific | 1.440% | 2.963% | 9.449% | 40.008% | 35.109% | 102.683% | 110.224% |
Waters Corp. | -0.030% | 1.143% | 18.452% | 32.016% | 8.411% | 27.891% | 75.814% |
Illumina Inc. | -1.930% | -3.388% | -8.401% | -46.745% | -21.432% | -68.859% | -62.621% |
Comments
News
QuidelOrtho Opens New Distribution Center in Pedricktown, NJ
QuidelOrtho Corporation (Nasdaq: QDEL) has launched a second state-of-the-art United States distribution center in Pedricktown, New Jersey. This strategic endeavor epitomizes QuidelOrtho’s
QuidelOrtho Reports First Quarter 2024 Financial Results
QuidelOrtho Corporation (Nasdaq: QDEL) (the “Company” or “QuidelOrtho”), a global provider of innovative in-vitro diagnostic technologies designed for point-of-care settings, clinical labs, and
QuidelOrtho Appoints Brian J. Blaser as President and Chief Executive Officer
QuidelOrtho Corporation (Nasdaq: QDEL) (the “Company” or “QuidelOrtho”), a global provider of innovative in-vitro diagnostic technologies designed for point of care settings, clinical labs and